REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Bolt Biotherapeutics Inc. (BOLT) on Wednesday reported a loss of $7.1 million in its third quarter.
On a per-share basis, the Redwood City, California-based company said it had a loss of $3.72.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $5.07 per share.
The company posted revenue of $2.2 million in the period.
In the final minutes of trading on Wednesday, the company's shares hit $4.69. A year ago, they were trading at $12.84.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BOLT at https://www.zacks.com/ap/BOLT
